Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Diseases | 2 | 2022 | 107 | 0.720 |
Why?
|
| Probiotics | 2 | 2017 | 14 | 0.720 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2022 | 122 | 0.710 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 111 | 0.670 |
Why?
|
| Diarrhea | 1 | 2016 | 63 | 0.560 |
Why?
|
| Constipation | 1 | 2016 | 32 | 0.550 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2014 | 1 | 0.500 |
Why?
|
| Terminology as Topic | 2 | 2017 | 141 | 0.360 |
Why?
|
| Colic | 2 | 2018 | 4 | 0.310 |
Why?
|
| Laparoscopy | 3 | 2017 | 237 | 0.310 |
Why?
|
| Growth | 1 | 2007 | 17 | 0.300 |
Why?
|
| Crohn Disease | 1 | 2007 | 38 | 0.290 |
Why?
|
| Prednisone | 1 | 2007 | 104 | 0.290 |
Why?
|
| Comprehensive Health Care | 2 | 2018 | 26 | 0.290 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 106 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 234 | 0.260 |
Why?
|
| Health Care Costs | 2 | 2018 | 346 | 0.230 |
Why?
|
| Inflammation | 3 | 2022 | 1030 | 0.220 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 337 | 0.220 |
Why?
|
| Fundoplication | 2 | 2014 | 27 | 0.220 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 59 | 0.220 |
Why?
|
| Wound Healing | 2 | 2004 | 260 | 0.220 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2022 | 5 | 0.210 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2022 | 5 | 0.210 |
Why?
|
| Gastric Bypass | 2 | 2014 | 83 | 0.210 |
Why?
|
| Mycobiome | 1 | 2022 | 1 | 0.210 |
Why?
|
| Insufflation | 1 | 2021 | 4 | 0.190 |
Why?
|
| Cellulose | 1 | 2021 | 22 | 0.190 |
Why?
|
| Autistic Disorder | 1 | 2022 | 77 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 2 | 2014 | 318 | 0.180 |
Why?
|
| Child | 6 | 2022 | 6405 | 0.180 |
Why?
|
| Dysbiosis | 1 | 2018 | 24 | 0.160 |
Why?
|
| Feces | 1 | 2018 | 88 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2021 | 254 | 0.150 |
Why?
|
| Biology | 1 | 2017 | 14 | 0.150 |
Why?
|
| Degloving Injuries | 1 | 2017 | 2 | 0.150 |
Why?
|
| Omentum | 1 | 2017 | 18 | 0.140 |
Why?
|
| Critical Illness | 1 | 2018 | 191 | 0.140 |
Why?
|
| Scalp | 1 | 2017 | 47 | 0.140 |
Why?
|
| Language | 1 | 2017 | 120 | 0.140 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2017 | 49 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2018 | 502 | 0.140 |
Why?
|
| Free Tissue Flaps | 1 | 2017 | 67 | 0.140 |
Why?
|
| Critical Care | 1 | 2018 | 263 | 0.130 |
Why?
|
| Surgical Flaps | 1 | 2017 | 120 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2016 | 97 | 0.130 |
Why?
|
| Humans | 16 | 2022 | 68618 | 0.130 |
Why?
|
| Rare Diseases | 1 | 2014 | 41 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 3259 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 191 | 0.120 |
Why?
|
| Robotics | 1 | 2014 | 56 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 219 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1174 | 0.100 |
Why?
|
| Immunosuppressive Agents | 2 | 2007 | 514 | 0.100 |
Why?
|
| Remission Induction | 2 | 2012 | 111 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2014 | 1330 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1851 | 0.080 |
Why?
|
| Male | 7 | 2018 | 37321 | 0.080 |
Why?
|
| South Carolina | 1 | 2014 | 2752 | 0.080 |
Why?
|
| Mercaptopurine | 1 | 2007 | 9 | 0.080 |
Why?
|
| Azathioprine | 1 | 2007 | 16 | 0.080 |
Why?
|
| Female | 8 | 2018 | 38074 | 0.070 |
Why?
|
| Infant | 3 | 2018 | 2891 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 649 | 0.060 |
Why?
|
| Adolescent | 3 | 2022 | 8912 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2017 | 7029 | 0.060 |
Why?
|
| Biomarkers | 2 | 2022 | 1593 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2004 | 124 | 0.060 |
Why?
|
| Translations | 1 | 2004 | 12 | 0.060 |
Why?
|
| Adult | 4 | 2014 | 21403 | 0.060 |
Why?
|
| Aminosalicylic Acids | 1 | 2003 | 2 | 0.060 |
Why?
|
| Quality of Life | 1 | 2012 | 1515 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1745 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2014 | 7277 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2014 | 216 | 0.050 |
Why?
|
| Spermine | 1 | 2022 | 49 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1864 | 0.050 |
Why?
|
| Eosinophils | 1 | 2022 | 60 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 333 | 0.050 |
Why?
|
| United States | 1 | 2014 | 7367 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2022 | 3187 | 0.050 |
Why?
|
| Amino Acids | 1 | 2022 | 131 | 0.050 |
Why?
|
| Fungi | 1 | 2022 | 27 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2018 | 2455 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2003 | 222 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2002 | 51 | 0.050 |
Why?
|
| Suspensions | 1 | 2021 | 11 | 0.050 |
Why?
|
| Desiccation | 1 | 2021 | 11 | 0.050 |
Why?
|
| Skin | 1 | 2004 | 451 | 0.050 |
Why?
|
| Anisotropy | 1 | 2021 | 105 | 0.050 |
Why?
|
| Length of Stay | 2 | 2014 | 780 | 0.050 |
Why?
|
| Hospitalization | 2 | 2018 | 978 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 511 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2021 | 78 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2002 | 212 | 0.040 |
Why?
|
| Time Factors | 1 | 2007 | 4655 | 0.040 |
Why?
|
| Acinetobacter | 1 | 2018 | 3 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2018 | 6 | 0.040 |
Why?
|
| Infant Formula | 1 | 2018 | 24 | 0.040 |
Why?
|
| Natural Science Disciplines | 1 | 2017 | 1 | 0.040 |
Why?
|
| History, 15th Century | 1 | 2017 | 6 | 0.040 |
Why?
|
| History, Medieval | 1 | 2017 | 8 | 0.040 |
Why?
|
| History, 16th Century | 1 | 2017 | 8 | 0.040 |
Why?
|
| History, 17th Century | 1 | 2017 | 17 | 0.040 |
Why?
|
| History, 18th Century | 1 | 2017 | 26 | 0.040 |
Why?
|
| History, Ancient | 1 | 2017 | 25 | 0.040 |
Why?
|
| Disease Transmission, Infectious | 1 | 2017 | 25 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 1342 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2017 | 95 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2017 | 127 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2017 | 248 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 1026 | 0.040 |
Why?
|
| Skin Transplantation | 1 | 2017 | 45 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2018 | 159 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 3705 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1553 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 45 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2014 | 101 | 0.030 |
Why?
|
| Cost Savings | 1 | 2014 | 110 | 0.030 |
Why?
|
| Mortality | 1 | 2014 | 163 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1738 | 0.030 |
Why?
|
| Risk | 1 | 2014 | 563 | 0.030 |
Why?
|
| Reoperation | 1 | 2014 | 467 | 0.030 |
Why?
|
| Patient Safety | 1 | 2014 | 202 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 652 | 0.030 |
Why?
|
| Animals | 2 | 2004 | 20881 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 711 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 14862 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2014 | 1615 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 5717 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 21147 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2002 | 88 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2002 | 294 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2002 | 175 | 0.010 |
Why?
|
| Regeneration | 1 | 2002 | 105 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 1752 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 2673 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 8474 | 0.010 |
Why?
|